ロード中...
A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia
BACKGROUND: Pentavalent antimonials (Sb5) are the first-line drugs for treating cutaneous leishmaniasis in Colombia; however, given problems with toxicity, compliance, availability, and cost, it is imperative to look for better therapeutic options. Intravenous amphotericin B (AmB) has been used exte...
保存先:
| 出版年: | PLoS Negl Trop Dis |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078324/ https://ncbi.nlm.nih.gov/pubmed/30044792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0006653 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|